General
Brisbane biotech company trials drug on US COVID-19 patients in bid to find ‘new way to prevent people dying’ of virus
A Brisbane biotech company, led by award-winning immunologist Ian Frazer, has created an anti-inflammatory drug, which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States.
Key points:
- The drug is being trailed on 300 people in the US, with results expected in about six months
- If successful, drug IC14 could become part of routine care to treat COVID-19 patients with severe infection
- Professor Ian Frazer says the drug could provide a new way to treat people dying from COVID-19
The new drug is not a vaccine but rather a treatment being trialled, and if proven successful, could become part of routine care in serious cases to prevent people dying from the virus.
Professor Frazer, who was the…
Continue Reading
-
Business14 hours ago3 ASX 200 blue chip shares to buy with $3,000 in July
-
Business15 hours ago2 great ASX shares to buy in July: experts
-
Business17 hours agoJP Morgan initiates coverage of Telix Pharmaceuticals. After rising 1,667% in 5 years, is it still a buy?
-
General9 hours agoChina hails PM’s ‘personal efforts’ to restore ties